Daniel E. Morse
Corporate Officer/Principal presso University of California, Santa Barbara
Posizioni attive di Daniel E. Morse
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of California, Santa Barbara | Corporate Officer/Principal | 01/01/1973 | - |
Storia della carriera di Daniel E. Morse
Precedenti posizioni note di Daniel E. Morse
Società | Posizione | Inizio | Fine |
---|---|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Direttore/Membro del Consiglio | 09/04/2010 | 28/09/2018 |
Independent Dir/Board Member | 09/04/2010 | 28/09/2018 | |
Stellar Biotechnologies, Inc. /Old/ | Direttore Tecnico/Scientifico/R&S | 19/04/2010 | 01/12/2011 |
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Direttore/Membro del Consiglio | 20/04/2010 | 20/04/2010 |
Corporate Officer/Principal | 20/04/2010 | 20/04/2010 | |
SBA Materials, Inc.
SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Fondatore | 21/07/2010 | - |
Formazione di Daniel E. Morse
Harvard University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Canada | 2 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Finance |
Stellar Biotechnologies, Inc. /Old/ | Health Technology |
SBA Materials, Inc.
SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Electronic Technology |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
- Borsa valori
- Insiders
- Daniel E. Morse
- Esperienza